Increased interleukin-6 production by cerebral cortical tissue of adult versus young mice

Mechanisms of Ageing and Development

Volumn 92, Issue 2-3, 1996, Pages 185-194

  Prechel, M Margaret ^a   Halbur, Luke ^a   Devata, Suma ^b   Vaidya, Abhay M ^a   Young, M Rita I ^a,b  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b HINES VA HOSPITAL   (United States)

Author keywords

Aging; Brain; Cerebral cortex; Development; Interleukin 6

Indexed keywords

INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA;

AGING; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN DEVELOPMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CEREBRAL CORTEX; CULTURE TECHNIQUES; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; STIMULATION, CHEMICAL; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030595982     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0047-6374(96)01833-7     Document Type: Article

References (33)

1. [1] L. Lafortune, J. Nalbantoglu and J.P. Antel, Expression of tumor necrosis factor-α (TNF α) and interleukin 6 (IL-6) mRNA in adult human astrocytes: comparison with adult microglia and fetal astrocytes. J. Neuropathol. Exp. Neurol., 55 (1996) 515-521.
2. [2] W.S. Sheng, S. Hu, F.H. Kravitz, P.K. Peterson and C.C. Chao, Tumor necrosis factor α upregulates human microglial cell production of interleukin-10 in vitro. Clin. Diag. Lab. Immunol., 2 (1995) 604-608.
3. [3] D.G. Walker, S.U. Kim and P.L. McGeer, Complement and cytokine gene expression in cultured microglial derived from postmortem human brains. J. Neurosci. Res., 40 (1995) 478-493.
4. [4] K.C. Williams, N.P. Dooley, E. Ulvestad et al., Antigen presentation by human fetal astrocytes with the cooperative effect of microglia or the microglial-derived cytokine IL-1. J. Neurosci., 15 (1995) 1869-1878.
5. [5] S.C. Lee, W. Liu, C.F. Brosnan and D.W. Dickson, GM-CSF promotes proliferation of human fetal and adult microglia in primary cultures. Glia, 12 (1994) 309-318.
6. [6] F. Aloisi, A. Care, G. Borsellino et al., Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1β and tumor necrosis fator-α. J. Immunol., 149 (1992) 2358-2366.
7. [7] T. Nitta, M. Ebato, K. Sato and K. Okumura, Expression of tumour necrosis factor-α, -β and interferon-γ genes within human neuroglial tumour cells and brain specimens. Cytokine, 6 (1994) 171-180.
8. [8] M. Bentivoglio, F. Florenzano, Z.C. Peng and K. Kristensson, Neuronal IFN-γ in tuberomammillary neurones. Neuroreport, 5 (1994) 2413-2416.
9. [9] C.C. Chao, S. Hu, T.W. Molitor, E.G. Shaskan and P.K. Peterson, Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J. Immunol., 149 (1992) 2736-2741.
10. [10] L. Meda, M.A. Cassateila, G.I. Szendrel et al., Activation of microglial cells by β-amyloid protein and interferon-γ. Nature, 374 (1995) 647-650.
11. [11] P.K. Peterson, S. Hu, W.R. Anderson and C.C. Chao, Nitric oxide production and neurotoxicity mediated by activated microglia from human versus mouse brain. J. Infect. Dis., 170 (1994) 457-460.
12. [12] J. Xu and E.A. Ling, Upregulation and induction of major histocompatibility complex class I and II antigens on microglial cells in early postnatal rat brain following intraperitoneal injections of recombinant interferon-γ. Neuroscience, 60 (1994) 959-967.
13. [13] S.C. Lee, W. Liu, P. Roth, D.W. Dickson, J.W. Berman and C.F. Brosnan, Macrophage colony-stimulating factor in human fetal astrocytes and microglia. J. Immunol., 150 (1993) 594-604.
14. [14] H. Akiyama, I. Tooyama, T. Kawamata, K. Ikeda and P.L. McGeer, Morphological diversities of CD44 positive astrocytes in the cerebral cortex of normal subjects and patients with Alzheimer's disease. Brain Res., 632 (1993) 249-259.
15. [15] J. Bauer, U. Ganter, S. Strauss et al., The participation of interleukin-6 in the pathogensis of Alzheimer's disease. Res. Immunol., 143 (1992) 650-657.
16. [16] P. Vandenabeele and W. Fiers, Is amyloidogenesis during Alzheimer's disease due to an IL-1/IL-6-mediated acute phase response in the brain? Immunol. Today, 12 (1991) 217-219.
17. [17] F.M. Brett, A.P. Mizisin, H.C. Powell and I.L. Campbell, Evolution of neuropathologic abnormalities associated with blood-brain barrier breakdown in transgenic mice expressing interleukin-6 in astrocytes. J. Neuropathol. Exp. Neurol., 54 (1995) 766-775.
18. [18] H.E. de Vries, M.C. Blom-Roosemalen, M. van Oosten et al., The influence of cytokines on the integrity of the blood-brain barrier in vitro. J. Neuroimmunol., 64 (1996) 37-43.
19. [19] M. Grimaldi, R. Arcone, G. Ciliberto and G. Schettini, Synergistic stimulation of interleukin 6 release and gene expression by phorbol esters and interleukin 1 β in rat cortical astrocytes: role of protein kinase C activation and blockade. J. Neurochem., 64 (1995) 1945-1953.
20. [20] C.S. Chiang, A. Stalder, A. Samimi and I.L. Campbell, Reactive gliosis as a consequence of interleukin-6 expression in the brain: studies in transgenic mice. Dev. Neurosci., 16 (1994) 212-221.
21. [21] G.E. Ringheim, K.L. Burgher and J.A. Heroux, Interleukin-6 mRNA expression by cortical neurons in culture: evidence for neuronal sources of interleukin-6 production in the brain. J. Neuroimmunol., 63 (1995) 113-123.
22. [22] C.C. Choa, S. Hu and P.K. Peterson, Modulation of human microglial cell superoxide production by cytokines. J. Leukocyte Biol., 58 (1995) 65-70.
23. [23] S. Hu, W.S. Sheng, P.K. Peterson and C.C. Chao, Cytokine modulation of murine microglial cell superoxide production. Glia, 13 (1995) 45-50.
24. 2 and a beta-andrenergic agonist. Glia, 11 (1994) 383-386.
25. [25] R. Kiefer, M.L. Supler, K.V. Toyka and W.J. Streit, In situ detection of transforming growth factor-β mRNA in experimental rat glioma and reactive glial cells. Neurosci. Lett., 166 (1994) 161-164.
26. [26] C.C. Chao, T.W. Molitor and S. Hu, Neuroprotective role of IL-4 against activated microglia. J. Immunol., 151 (1993) 1473-1481.
27. [27] S.J. Khoury, W.W. Hancock and H.L. Weiner, Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain. J. Exp. Med., 176 (1992) 1355-1364.
28. [28] M.R.I. Young, T. Farietta and J.W. Crayton, Brain production of nitric oxide and transforming growth factor-β. Mech. Ageing Dev., 79 (1995) 115-126.
29. [29] E.N. Benveniste, J. Kwon, W.J. Chung, J. Sampson, K. Pandya and L.P. Tang, Differential modulation of astrocyte cytokine gene expression by TGF-β. J. Immunol., 153 (1994) 5210-5221.
30. [30] C.C. Chao, S. Hu, F.H. Kravitz, M. Tsang, W.R. Anderson and P.K. Peterson, Transforming growth factor-β protects human neurons against β-amyloid-induced injury. J. Immunol., 23 (1994) 159-178.
31. [31] T.E. Morgan, N.R. Nichols, G.M. Pasinetti and C.E. Finch, TGF-β1 mRNA increases in macrophage/microglia cells of the hippocampus in response to deafferentation and kainic acid-induced neurodegeneration. Exp. Neurol., 120 (1993) 291-301.
32. [32] L. Calza, L. Giardino and S. Ceccatelli, NOS mRNA in the paraventricular nucleus of young and old rats after immobilization stress. Neuroreport, 4 (1993) 627-630.
33. [33] M. Strolin Benedetti, P. Dostert, P. Marrari and M. Cini, Effect of ageing on tissue levels of amino acids involved in the nitric oxide pathway in rat brain. J. Neural Trans., 94 (1993) 21-30.